Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Pure Extracts Technologies Corp. (PULL) has submitted a licence application to Health Canada for a new blended functional mushroom wellness product
  • The new product provides antioxidants that help protect cells against the oxidative damage caused by free radicals
  • The blended formula is expected to launch in the fourth quarter of 2021
  • Pure Extracts Technologies is a plant-based extraction company
  • Pure Extracts Technologies Corp. (PULL) is up 2.44 per cent, trading at $0.42 per share

Pure Extracts Technologies Corp. (PULL) has submitted a licence application to Health Canada for a new blended functional mushroom wellness product.

Ben Nikolaevsky, Pure Extracts CEO, commented on the company’s recent progress.

“We are excited to be creating our next Pure Mushrooms products for our direct-to-consumer, online store,” he said. “As we build-out our mushroom extraction facility, we plan to bring more products to market.”

The application is for a blend of cordyceps, reishi, and lion’s mane mushrooms, following up on the company’s Amazon launch of its reishi and maitake formulations.

The new blended formula provides antioxidants that help protect cells against the oxidative damage caused by free radicals.

“The functional mushroom wellness market is experiencing robust sales,” added Mr. Nikolaevsky, “as many consumers are trying to boost their immune systems in light of the COVID-19 pandemic.”

The reishi and maitake formulations sold on the company’s Amazon e-commerce store have proven to be appealing to both men and women, with the most sales in California, Florida, and Georgia.

The blended formula is expected to launch in the fourth quarter of 2021, pending approval from Health Canada’s Natural and Non-Prescription Health Products Directorate.

Pure Extracts Technologies is a plant-based extraction company that specializes in the processing of cannabis, hemp and functional mushrooms.

The company’s new, state-of-the-art processing facility is located just 20 minutes north of Whistler, British Columbia.

Pure Extracts Technologies Corp. (PULL) is up 2.44 per cent, trading at $0.42 per share as of 2:24 pm ET.

More From The Market Herald

" Optimi Health (CSE:OPTI) signs psilocybin supply agreement with Halucenex Life Sciences

Optimi Health (OPTI) has announced a supply agreement with Halucenex Life Sciences Inc., a wholly-owned subsidiary of Creso Pharma of Australia.

" Revive (CSE:RVV) gets FDA OK for Bucillamine trials to treat COVID-19

Revive Therapeutics (RVV), a cannabis and psychedelic healthcare company has received feedback from the U.S. FDA to help advance Bucillamine.

" Clearmind Medicine (CSE:MIND) and SciSparc report positive results for Psychedelic Combination Treatment

Clearmind Medicine (MND) has released favourable safety profile results from its joint pre-clinical trial with SciSparc Ltd. (NASDAQ: SPRC).

" Optimi Health (CSE:OPTI) acquires catalog of psychedelic and functional mushroom genetics

Optimi Health (OPTI) has acquired a catalog of psilocybin and functional mushroom strains.